Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in FBRX — Forte Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in FBRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$304,108
-$3,153,386 QoQ
Shares Held
14,311
-89.3% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 85 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FBRX Over Time

Shares Held

Position Value (USD)

Derivatives in FBRX

reported options exposure · as of Jun 30, 2026
CallValue
$293,250
CallShares
13,800
PutValue
$1,797,750
PutShares
84,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. FBRX ranks #194 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FBRX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $293,250 13,800
2026-06-30 $304,108 14,311
2026-06-30 $1,797,750 84,600
2026-03-31 $593,110 22,900
2026-03-31 $3,457,494 133,494
2026-03-31 $890,960 34,400
2025-12-31 $1,442,964 52,914
2024-09-30 $73,206 13,096
2024-06-30 $18,442 34,344
2023-06-30 $31,531 30,319
2023-03-31 $10,427 10,324
2022-12-31 $13,435 13,435
2022-06-30 $153,028 117,714
2022-06-30 $1,310,010 1,007,700
2022-03-31 $40,201 27,535
2021-12-31 $116,416 54,400
2021-12-31 $136,960 64,000
2021-12-31 $152,151 71,099
2021-09-30 $175,528 59,300
2021-09-30 $663,697 224,222
2021-09-30 $782,920 264,500
2021-03-31 $1,800,751 52,546
2020-09-30 $218,683 4,508
2020-06-30 $300,348 20,600
2020-03-31 TOCA 37,400
2020-03-31 TOCA 12,400